Miconazole is a broad-spectrum azole antifungal with some activity against Gram-positive bacteria as well. It is widely used to treat mucosal yeast infections, including both oral and vaginal infections; although intravenous miconazole is no longer available, a wide variety of suppositories, creams, gels, and tablet-based products are available. Miconazole is thought to act mainly through the inhibition of fungal CYP450 14α-lanosterol demethylase activity. Miconazole was first synthesized in 1969 and first granted FDA approval on January 8, 1974, for sale by INSIGHT Pharmaceuticals as a topical cream. It is currently available as a variety of prescription and over the counter products. Despite having been in clinical use for an extended period, resistance to miconazole among susceptible organisms is relatively low. Its therapeutic use is listed as antifungals and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Daktarin, Oravig, Daktarin IV, Dermazole and Dumicoat. Its PubChem CID is 4189.
Miconazole
| CAS No | 22916-47-8 |
|---|---|
| Molecular Formula | C18H14Cl4N2O |
| Molecular Weight | 416.0 g/mol |
| Synonyms | 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Miconazole is a broad-spectrum azole antifungal with some activity against Gram-positive bacteria as well.
The listed CAS number is 22916-47-8.
The listed molecular formula is C18H14Cl4N2O.
The listed molecular weight is 416.0 g/mol.
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole.
The source lists Daktarin, Oravig, Daktarin IV, Dermazole and Dumicoat.